Cambridge, MA, United States of America

Yingxia Wen

This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Seqirus UK Limited. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yingxia Wen. Retrieved from https://idiyas.com/inventor/yingxia-wen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Acton, MA (US) (2017 - 2019)
  • Cambridge, MA (US) (2019 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Yingxia Wen

Introduction

Yingxia Wen, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of biomedicine through his inventive expertise. With a total of seven patents to his name, his work specifically focuses on advanced RNA purification methods and robust assays for influenza vaccine potency. His innovations are setting new standards in both efficiency and effectiveness in biotechnological applications.

Latest Patents

Yingxia Wen's latest patents include pioneering methods for RNA purification. These methods involve techniques such as tangential flow filtration, hydroxyapatite chromatography, and core bead flow-through chromatography, which can be used individually or in combination for optimum results. The advancements in these techniques allow for highly efficient RNA purification without compromising the potency or stability of the samples. Moreover, these methods do not require organic solvents, making them more environmentally friendly. Another key patent of his is focused on stability-indicating potency assays for influenza vaccines, aiming to enhance the reliability and effectiveness of vaccine evaluations.

Career Highlights

During his career, Yingxia Wen has collaborated with notable companies in the pharmaceutical and biotechnology sectors. He has held positions at GlaxoSmithKline Biologicals S.A. and Seqirus UK Limited, contributing to innovative research and development initiatives. His expertise has been instrumental in facilitating advancements in vaccine technologies and RNA research.

Collaborations

Yingxia Wen's work is further enriched by collaborations with esteemed colleagues, including Andrea Carfi and Andrew John Geall. These partnerships reveal a strong commitment to advancing scientific knowledge and improving health outcomes through innovative research.

Conclusion

Yingxia Wen's contributions to RNA purification techniques and influenza vaccine potency assays underscore the importance of innovation in the biomedical field. His patents not only reflect his ingenuity as an inventor but also promise significant advancements in medical research and public health. With continued collaboration and dedication, his work will likely lead to further breakthroughs in biotechnology and health sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…